- Home
- IIIV vs LENZ Comparison
IIIV vs LENZ Comparison
Compare IIIV & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IIIV | LENZ |
|---|---|---|
| Founded | 2012 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 642.1M | 609.5M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | IIIV | LENZ |
|---|---|---|
| Price | $23.21 | $11.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $33.20 | ★ $56.25 |
| AVG Volume (30 Days) | 342.7K | ★ 646.7K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.05 | N/A |
| Revenue Next Year | $8.07 | $157.21 |
| P/E Ratio | $1,161.00 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $19.89 | $11.48 |
| 52 Week High | $33.97 | $50.19 |
Technical Indicators
Market Signals| Indicator | IIIV | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 52.80 | 37.07 |
| Support Level | $22.51 | $11.48 |
| Resistance Level | $23.36 | $14.97 |
| Average True Range (ATR) | 0.77 | 0.86 |
| MACD | 0.22 | 0.11 |
| Stochastic Oscillator | 69.14 | 14.90 |
Price Performance
Historical ComparisonAbout IIIV i3 Verticals Inc.
i3 Verticals Inc provides mission-critical enterprise software solutions to public sector entities. These comprehensive cloud-native solutions address a broad range of government functions, including courts and public safety, public administration, utilities, transportation and schools. The company generates the majority of revenue from software and related services, including the sale of subscriptions, recurring services, ongoing support, licenses, and installation and implementation services specific to software.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.